Patents by Inventor Peter James Lindsay-Scott

Peter James Lindsay-Scott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 5-methyl-4-fluoro-thiazol-2-yl compounds
    Patent number: 11999726
    Abstract: The present invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treating neurodegenerative diseases, such as Alzheimers disease.
    Type: Grant
    Filed: July 24, 2019
    Date of Patent: June 4, 2024
    Inventors: Nicolas Jacques Francois Dreyfus, Peter James Lindsay-Scott
  • 5-METHYL-4-FLUORO-THIAZOL-2-YL COMPOUNDS
    Publication number: 20210323958
    Abstract: The present invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treating neurodegenerative diseases, such as Alzheimers disease.
    Type: Application
    Filed: July 24, 2019
    Publication date: October 21, 2021
    Inventors: Nicolas Jacques Francois DREYFUS, Peter James LINDSAY-SCOTT
  • 5-methyl-1,3,4-oxadiazol-2-yl compounds
    Patent number: 10377750
    Abstract: The present invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treatment of neurodegenerative diseases and disorders, such as Alzheimer's disease.
    Type: Grant
    Filed: May 18, 2018
    Date of Patent: August 13, 2019
    Assignee: Eli Lilly and Company
    Inventors: Nicolas Jacques Francois Dreyfus, Peter James Lindsay-Scott, Richard Edmund Rathmell
  • 5-METHYL-1,3,4-OXADIAZOL-2-YL COMPOUNDS
    Publication number: 20180339984
    Abstract: The present invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treatment of neurodegenerative diseases and disorders, such as Alzheimer's disease.
    Type: Application
    Filed: May 18, 2018
    Publication date: November 29, 2018
    Inventors: Nicolas Jacques Francois Dreyfus, Peter James Lindsay-Scott, Richard Edmund Rathmell
  • 5-methyl-1,2,4-oxadiazol-3-yl compounds
    Patent number: 10081625
    Abstract: The present invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treatment of neurodegenerative diseases and disorders, such as Alzheimer's disease.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: September 25, 2018
    Assignee: Eli Lilly and Company
    Inventors: Nicolas Jacques Francois Dreyfus, Peter James Lindsay-Scott
  • 5-METHYL-1,2,4-OXADIAZOL-3-YL COMPOUNDS
    Publication number: 20180215751
    Abstract: The present invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treatment of neurodegenerative diseases and disorders, such as Alzheimer's disease.
    Type: Application
    Filed: January 19, 2018
    Publication date: August 2, 2018
    Applicant: Eli Lilly and Company
    Inventors: Nicolas Jacques Francois Dreyfus, Peter James Lindsay-Scott